245 related articles for article (PubMed ID: 35144669)
61. Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer.
Smith EM; Pawlita M; Rubenstein LM; Haugen TH; Hamsikova E; Turek LP
Int J Cancer; 2010 Jul; 127(1):111-7. PubMed ID: 19876924
[TBL] [Abstract][Full Text] [Related]
62. Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma.
Dogra S; Bandi S; Viswanathan P; Gupta S
Cancer Lett; 2015 Jan; 356(2 Pt B):953-61. PubMed ID: 25444910
[TBL] [Abstract][Full Text] [Related]
63. Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation.
Bornstein S; White R; Malkoski S; Oka M; Han G; Cleaver T; Reh D; Andersen P; Gross N; Olson S; Deng C; Lu SL; Wang XJ
J Clin Invest; 2009 Nov; 119(11):3408-19. PubMed ID: 19841536
[TBL] [Abstract][Full Text] [Related]
64. DNA-Pk
Weaver AN; Cooper TS; Wei S; Carroll WR; Rosenthal EL; Yang ES
Head Neck; 2017 Feb; 39(2):206-214. PubMed ID: 27507640
[TBL] [Abstract][Full Text] [Related]
65. Head and neck cancer stem cells: the effect of HPV--an in vitro and mouse study.
Tang AL; Owen JH; Hauff SJ; Park JJ; Papagerakis S; Bradford CR; Carey TE; Prince ME
Otolaryngol Head Neck Surg; 2013 Aug; 149(2):252-60. PubMed ID: 23585151
[TBL] [Abstract][Full Text] [Related]
66. HSP90 inhibition sensitizes head and neck cancer to platin-based chemoradiotherapy by modulation of the DNA damage response resulting in chromosomal fragmentation.
McLaughlin M; Barker HE; Khan AA; Pedersen M; Dillon M; Mansfield DC; Patel R; Kyula JN; Bhide SA; Newbold KL; Nutting CM; Harrington KJ
BMC Cancer; 2017 Jan; 17(1):86. PubMed ID: 28143445
[TBL] [Abstract][Full Text] [Related]
67. Effect of ATR Inhibition in RT Response of HPV-Negative and HPV-Positive Head and Neck Cancers.
Dok R; Glorieux M; Bamps M; Nuyts S
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546122
[TBL] [Abstract][Full Text] [Related]
68. CHK1/2 Inhibitor Prexasertib Suppresses NOTCH Signaling and Enhances Cytotoxicity of Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma.
Zeng L; Nikolaev A; Xing C; Della Manna DL; Yang ES
Mol Cancer Ther; 2020 Jun; 19(6):1279-1288. PubMed ID: 32371584
[TBL] [Abstract][Full Text] [Related]
69. Resveratrol selectively induces DNA Damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma.
Tyagi A; Gu M; Takahata T; Frederick B; Agarwal C; Siriwardana S; Agarwal R; Sclafani RA
Clin Cancer Res; 2011 Aug; 17(16):5402-11. PubMed ID: 21705453
[TBL] [Abstract][Full Text] [Related]
70. Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures.
Zhang Y; Koneva LA; Virani S; Arthur AE; Virani A; Hall PB; Warden CD; Carey TE; Chepeha DB; Prince ME; McHugh JB; Wolf GT; Rozek LS; Sartor MA
Clin Cancer Res; 2016 Sep; 22(18):4735-45. PubMed ID: 27091409
[TBL] [Abstract][Full Text] [Related]
71. Effects of β-HPV on DNA damage response pathways to drive carcinogenesis: a review.
Tahseen D; Rady PL; Tyring SK
Virus Genes; 2021 Feb; 57(1):23-30. PubMed ID: 33392984
[TBL] [Abstract][Full Text] [Related]
72. NF-κB1 Intronic Region Polymorphisms as Risk Factor for Head and Neck Cancer in HPV-Infected Population from Pakistan.
Sarwar S; Tareen MU; Sabir M; Sultan A; Malik SA
Curr Mol Med; 2022; 22(1):74-82. PubMed ID: 33653249
[TBL] [Abstract][Full Text] [Related]
73. Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.
Eytan DF; Blackford AL; Eisele DW; Fakhry C
Cancer; 2019 Jan; 125(2):249-260. PubMed ID: 30444527
[TBL] [Abstract][Full Text] [Related]
74. Effect of human papillomavirus 16 oncoproteins on oncostatin M upregulation in oral squamous cell carcinoma.
Chuerduangphui J; Pientong C; Chaiyarit P; Patarapadungkit N; Chotiyano A; Kongyingyoes B; Promthet S; Swangphon P; Wongjampa W; Ekalaksananan T
Med Oncol; 2016 Aug; 33(8):83. PubMed ID: 27349249
[TBL] [Abstract][Full Text] [Related]
75. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.
Masterson L; Winder DM; Ball SL; Vaughan K; Lehmann M; Scholtz LU; Sterling JC; Sudhoff HH; Goon PK
BMC Cancer; 2016 Jun; 16():367. PubMed ID: 27296171
[TBL] [Abstract][Full Text] [Related]
76. TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects.
Wang L; Zhang P; Molkentine DP; Chen C; Molkentine JM; Piao H; Raju U; Zhang J; Valdecanas DR; Tailor RC; Thames HD; Buchholz TA; Chen J; Ma L; Mason KA; Ang KK; Meyn RE; Skinner HD
Oncogene; 2017 Feb; 36(6):820-828. PubMed ID: 27425591
[TBL] [Abstract][Full Text] [Related]
77. Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints.
Molkentine JM; Molkentine DP; Bridges KA; Xie T; Yang L; Sheth A; Heffernan TP; Clump DA; Faust AZ; Ferris RL; Myers JN; Frederick MJ; Mason KA; Meyn RE; Pickering CR; Skinner HD
Int J Radiat Biol; 2021; 97(8):1121-1128. PubMed ID: 32073931
[TBL] [Abstract][Full Text] [Related]
78. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
[TBL] [Abstract][Full Text] [Related]
79. Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer.
Park JW; Pitot HC; Strati K; Spardy N; Duensing S; Grompe M; Lambert PF
Cancer Res; 2010 Dec; 70(23):9959-68. PubMed ID: 20935219
[TBL] [Abstract][Full Text] [Related]
80. Incidence trends of human papillomavirus-related head and neck cancer in Taiwan, 1995-2009.
Hwang TZ; Hsiao JR; Tsai CR; Chang JS
Int J Cancer; 2015 Jul; 137(2):395-408. PubMed ID: 25395239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
